Clinical Research

56-Day Clinical Study: How C. asiatica Extracellular Vesicles & Recombinant Growth Factors Restore Hair Density and Reduce Hair Loss

Senye-Zhongyan-Youke Research Team·Biotech Cosmetic Research InstitutionMay 13, 20265 min read
56-Day Clinical Study: How C. asiatica Extracellular Vesicles & Recombinant Growth Factors Restore Hair Density and Reduce Hair Loss

A 56-day double-blind clinical trial by Senye-Zhongyan-Youke confirms that plant-derived C. asiatica EVs combined with rIGF-1 & rFGF-7 growth factors reduce daily hair loss by 63.6% and increase hair density by 23.9%. Science-backed, non-pharmaceutical hair care.

Introduction: A Science-Backed Answer to Hair Loss

Hair loss affects hundreds of millions of people worldwide, impacting confidence and quality of life. Senye-Zhongyan-Youke developed a biotech-driven scalp serum combining Centella asiatica Extracellular Vesicles (C. asiatica EVs) with long-acting Recombinant Growth Factors (rIGF-1 and rFGF-7), validated in a 56-day randomized, double-blind, placebo-controlled clinical trial (ClinicalTrials.gov: NCT06985121).


How This Formula Works

1. C. asiatica EVs — Plant-Derived Nanocarriers

Derived from Centella asiatica (Gotu Kola), these EVs penetrate deeply into the scalp to:

  • Reduce scalp inflammation — a key driver of follicle miniaturization
  • Regulate excess sebum production
  • Activate dermal papilla cells to initiate and sustain hair growth

2. Recombinant Growth Factors: rIGF-1 & rFGF-7

Engineered with Fc-fusion technology for extended biological half-life, these growth factors:

  • Prolong the anagen (growth) phase of the hair cycle
  • Prevent premature follicle entry into the catagen (regression) phase
  • Stimulate hair shaft thickening and structural integrity

Clinical Trial Design

Parameter Details
Duration 56 days
Design Randomized, Double-Blind, Placebo-Controlled
Registration NCT06985121
Institution Senye-Zhongyan-Youke
Test Group Group E — Full Formula

Day 56 Results (Group E — Full Formula)

Scalp Sebum Control: −59%

Restores a balanced scalp microenvironment, reducing conditions that accelerate follicle damage.

Hair Length Growth: +3.5 cm

Statistically significant growth differences observed from Day 14 onward.

Hair Diameter (Thickness): +27.9 μm

Thicker hair shafts mean visibly fuller, more resilient hair with reduced breakage.

Hair Density: +23.9%

Measurable increase in follicular unit count per area — significant improvement in overall volume.

Daily Hair Loss: −63.6%

The standout result: nearly two-thirds fewer hairs shed per day compared to baseline.


Conclusion

The combination of plant-derived EVs and long-acting recombinant growth factors delivers a synergistic, multi-target effect — addressing sebum control, growth stimulation, density, and hair loss simultaneously. A safe, effective, science-backed non-pharmaceutical solution for hair and scalp rejuvenation.


About Senye-Zhongyan-Youke

A biotech-driven cosmetic research institution developing clinically validated, plant-science solutions for scalp and hair health.

Tags:hair loss treatmenthair growth serumCentella asiatica extracellular vesiclesrecombinant growth factorsscalp healthclinical studyrIGF-1rFGF-7hair densityanti-hair lossbiotech cosmeticsSenye-Zhongyan-Youke

Share this article

Senye-Zhongyan-Youke Research Team

Biotech Cosmetic Research Institution

Publication details are shown from the article record. Individual expertise, reviewer information, and review dates appear only when verified for public display.

Starting MOQ: Starting MOQ is subject to formula, packaging and market documentation; request a project-specific quotation.·Quote response SLA: Within 1 business day after we receive a complete project inquiry.